<!DOCTYPE html>
<html lang="" xml:lang="">
  <head>
    <title>Market Valuation of Corporate Technological Assets:   The Case of Japan’s Institutional Adaptability</title>
    <meta charset="utf-8" />
    <meta name="author" content="Kostiantyn Ovsiannikov, Ph.D." />
    <meta name="date" content="2021-06-24" />
    <script src="libs/header-attrs/header-attrs.js"></script>
    <link href="libs/remark-css/rutgers-fonts.css" rel="stylesheet" />
    <script src="libs/fabric/fabric.min.js"></script>
    <link href="libs/xaringanExtra-scribble/scribble.css" rel="stylesheet" />
    <script src="libs/xaringanExtra-scribble/scribble.js"></script>
    <script>document.addEventListener('DOMContentLoaded', function() { window.xeScribble = new Scribble({"pen_color":["#FF0000"],"pen_size":3,"eraser_size":30,"palette":[]}) })</script>
    <link href="libs/tile-view/tile-view.css" rel="stylesheet" />
    <script src="libs/tile-view/tile-view.js"></script>
    <link href="libs/tachyons/tachyons.min.css" rel="stylesheet" />
    <link href="libs/panelset/panelset.css" rel="stylesheet" />
    <script src="libs/panelset/panelset.js"></script>
    <script src="libs/clipboard/clipboard.min.js"></script>
    <link href="libs/shareon/shareon.min.css" rel="stylesheet" />
    <script src="libs/shareon/shareon.min.js"></script>
    <link href="libs/xaringanExtra-shareagain/shareagain.css" rel="stylesheet" />
    <script src="libs/xaringanExtra-shareagain/shareagain.js"></script>
    <script src="libs/js-cookie/js.cookie.js"></script>
    <script src="libs/peerjs/peerjs.min.js"></script>
    <script src="libs/tiny.toast/toast.min.js"></script>
    <link href="libs/xaringanExtra-broadcast/broadcast.css" rel="stylesheet" />
    <script src="libs/xaringanExtra-broadcast/broadcast.js"></script>
    <script src="libs/mark.js/mark.min.js"></script>
    <link href="libs/xaringanExtra-search/search.css" rel="stylesheet" />
    <script src="libs/xaringanExtra-search/search.js"></script>
    <script>window.addEventListener('load', function() { window.xeSearch = new RemarkSearch({"position":"bottom-left","caseSensitive":false,"showIcon":true,"autoSearch":true}) })</script>
    <link href="libs/xaringanExtra-extra-styles/xaringanExtra-extra-styles.css" rel="stylesheet" />
    <script src="libs/xaringanExtra-progressBar/progress-bar.js"></script>
    <meta name="github-repo" content="ko-suta/Academic-Website"/>
    <meta name="twitter:title" content="Market Valuation of Corporate Technological Assets: &lt;br&gt; The Case of Japan&#39;s Institutional Adaptability."/>
    <meta name="twitter:description" content="Market Valuation of Corporate Technological Assets. Presented at 2021 AJBS Conference."/>
    <meta name="twitter:url" content="https://kovsiannikov.com/slides/ajbs-2021/ajbs-2021"/>
    <meta name="twitter:image:src" content="https://kovsiannikov.com/img/Techno-screen.png"/>
    <meta name="twitter:image:alt" content="2021 AJBS Conference Presentation"/>
    <meta name="twitter:card" content="summary_large_image"/>
    <meta name="twitter:creator" content="@ko_suta"/>
    <meta name="twitter:site" content="@ko_suta"/>
    <meta property="og:title" content="Market Valuation of Corporate Technological Assets: &lt;br&gt; The Case of Japan&#39;s Institutional Adaptability."/>
    <meta property="og:description" content="Market Valuation of Corporate Technological Assets. Presented at 2021 AJBS Conference."/>
    <meta property="og:url" content="https://kovsiannikov.com/slides/ajbs-2021/ajbs-2021"/>
    <meta property="og:image" content="https://kovsiannikov.com/img/Techno-screen.png"/>
    <meta property="og:image:alt" content="2021 AJBS Conference Presentation"/>
    <meta property="og:type" content="website"/>
    <meta property="og:locale" content="en_US"/>
    <meta property="article:author" content="Kostiantyn Ovsiannikov"/>
    <link href="libs/font-awesome-animation/font-awesome-animation-emi.css" rel="stylesheet" />
    <script src="libs/fontawesome/js/fontawesome-all.min.js"></script>
    <script src="libs/htmlwidgets/htmlwidgets.js"></script>
    <script src="libs/jquery/jquery.min.js"></script>
    <link href="libs/datatables-css/datatables-crosstalk.css" rel="stylesheet" />
    <script src="libs/datatables-binding/datatables.js"></script>
    <link href="libs/dt-core/css/jquery.dataTables.min.css" rel="stylesheet" />
    <link href="libs/dt-core/css/jquery.dataTables.extra.css" rel="stylesheet" />
    <script src="libs/dt-core/js/jquery.dataTables.min.js"></script>
    <link href="libs/crosstalk/css/crosstalk.css" rel="stylesheet" />
    <script src="libs/crosstalk/js/crosstalk.min.js"></script>
    <script src="libs/kePrint/kePrint.js"></script>
    <link href="libs/lightable/lightable.css" rel="stylesheet" />
    <link rel="stylesheet" href="rutgers-new.css" type="text/css" />
  </head>
  <body>
    <textarea id="source">
class: center, middle, inverse, title-slide

# Market Valuation of Corporate Technological Assets: <br> The Case of Japan’s Institutional Adaptability
## 2021 AJBS Conference
### Kostiantyn Ovsiannikov, Ph.D.
### .white.bg-green[Kochi University of Technology]
### 24 June 2021

---








<style>.shareagain-bar {
--shareagain-foreground: white;
--shareagain-background: black;
--shareagain-pinterest: none;
--shareagain-pocket: none;
--shareagain-reddit: none;
}</style><div>
<style type="text/css">.xaringan-extra-logo {
width: 220px;
height: 256px;
z-index: 0;
background-image: url(assets/img/KUT.jpg);
background-size: contain;
background-repeat: no-repeat;
position: absolute;
top:2em;right:2em;
}
</style>
<script>(function () {
  let tries = 0
  function addLogo () {
    if (typeof slideshow === 'undefined') {
      tries += 1
      if (tries < 10) {
        setTimeout(addLogo, 100)
      }
    } else {
      document.querySelectorAll('.remark-slide-content:not(.hide_logo)')
        .forEach(function (slide) {
          const logo = document.createElement('div')
          logo.classList = 'xaringan-extra-logo'
          logo.href = null
          slide.appendChild(logo)
        })
    }
  }
  document.addEventListener('DOMContentLoaded', addLogo)
})()</script>
</div><style>.xe__progress-bar__container {
  top:0;
  opacity: 1;
  position:absolute;
  right:0;
  left: 0;
}
.xe__progress-bar {
  height: 10px;
  background-color: #0051BA;
  width: calc(var(--slide-current) / var(--slide-total) * 100%);
}
.remark-visible .xe__progress-bar {
  animation: xe__progress-bar__wipe 200ms forwards;
  animation-timing-function: cubic-bezier(.86,0,.07,1);
}
@keyframes xe__progress-bar__wipe {
  0% { width: calc(var(--slide-previous) / var(--slide-total) * 100%); }
  100% { width: calc(var(--slide-current) / var(--slide-total) * 100%); }
}</style>







# Background: Japan's intrapreneurial regime

--

.pull-left-narrow[
.center[### <svg aria-hidden="true" role="img" viewBox="0 0 640 512" style="height:1em;width:1.25em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:green;overflow:visible;position:relative;"><path d="M128 96c26.5 0 48-21.5 48-48S154.5 0 128 0 80 21.5 80 48s21.5 48 48 48zm384 0c26.5 0 48-21.5 48-48S538.5 0 512 0s-48 21.5-48 48 21.5 48 48 48zm125.7 372.1l-44-110-41.1 46.4-2 18.2 27.7 69.2c5 12.5 17 20.1 29.7 20.1 4 0 8-.7 11.9-2.3 16.4-6.6 24.4-25.2 17.8-41.6zm-34.2-209.8L585 178.1c-4.6-20-18.6-36.8-37.5-44.9-18.5-8-39-6.7-56.1 3.3-22.7 13.4-39.7 34.5-48.1 59.4L432 229.8 416 240v-96c0-8.8-7.2-16-16-16H240c-8.8 0-16 7.2-16 16v96l-16.1-10.2-11.3-33.9c-8.3-25-25.4-46-48.1-59.4-17.2-10-37.6-11.3-56.1-3.3-18.9 8.1-32.9 24.9-37.5 44.9l-18.4 80.2c-4.6 20 .7 41.2 14.4 56.7l67.2 75.9 10.1 92.6C130 499.8 143.8 512 160 512c1.2 0 2.3-.1 3.5-.2 17.6-1.9 30.2-17.7 28.3-35.3l-10.1-92.8c-1.5-13-6.9-25.1-15.6-35l-43.3-49 17.6-70.3 6.8 20.4c4.1 12.5 11.9 23.4 24.5 32.6l51.1 32.5c4.6 2.9 12.1 4.6 17.2 5h160c5.1-.4 12.6-2.1 17.2-5l51.1-32.5c12.6-9.2 20.4-20 24.5-32.6l6.8-20.4 17.6 70.3-43.3 49c-8.7 9.9-14.1 22-15.6 35l-10.1 92.8c-1.9 17.6 10.8 33.4 28.3 35.3 1.2.1 2.3.2 3.5.2 16.1 0 30-12.1 31.8-28.5l10.1-92.6 67.2-75.9c13.6-15.5 19-36.7 14.4-56.7zM46.3 358.1l-44 110c-6.6 16.4 1.4 35 17.8 41.6 16.8 6.6 35.1-1.7 41.6-17.8l27.7-69.2-2-18.2-41.1-46.4z"/></svg>]]
.pull-right-wide[### large companies <svg aria-hidden="true" role="img" viewBox="0 0 640 512" style="height:1em;width:1.25em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:blue;overflow:visible;position:relative;"><path d="M434.7 64h-85.9c-8 0-15.7 3-21.6 8.4l-98.3 90c-.1.1-.2.3-.3.4-16.6 15.6-16.3 40.5-2.1 56 12.7 13.9 39.4 17.6 56.1 2.7.1-.1.3-.1.4-.2l79.9-73.2c6.5-5.9 16.7-5.5 22.6 1 6 6.5 5.5 16.6-1 22.6l-26.1 23.9L504 313.8c2.9 2.4 5.5 5 7.9 7.7V128l-54.6-54.6c-5.9-6-14.1-9.4-22.6-9.4zM544 128.2v223.9c0 17.7 14.3 32 32 32h64V128.2h-96zm48 223.9c-8.8 0-16-7.2-16-16s7.2-16 16-16 16 7.2 16 16-7.2 16-16 16zM0 384h64c17.7 0 32-14.3 32-32V128.2H0V384zm48-63.9c8.8 0 16 7.2 16 16s-7.2 16-16 16-16-7.2-16-16c0-8.9 7.2-16 16-16zm435.9 18.6L334.6 217.5l-30 27.5c-29.7 27.1-75.2 24.5-101.7-4.4-26.9-29.4-24.8-74.9 4.4-101.7L289.1 64h-83.8c-8.5 0-16.6 3.4-22.6 9.4L128 128v223.9h18.3l90.5 81.9c27.4 22.3 67.7 18.1 90-9.3l.2-.2 17.9 15.5c15.9 13 39.4 10.5 52.3-5.4l31.4-38.6 5.4 4.4c13.7 11.1 33.9 9.1 45-4.7l9.5-11.7c11.2-13.8 9.1-33.9-4.6-45.1z"/></svg> financial institutions]

--

.pull-left-narrow[
.center[### <svg aria-hidden="true" role="img" viewBox="0 0 512 512" style="height:1em;width:1em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:green;overflow:visible;position:relative;"><path d="M511.9 175c-9.1-75.6-78.4-132.4-158.3-158.7C390 55.7 416 116.9 416 192h28.1L327.5 321.5c-2.5-.6-4.8-1.5-7.5-1.5h-48V192h112C384 76.8 315.1 0 256 0S128 76.8 128 192h112v128h-48c-2.7 0-5 .9-7.5 1.5L67.9 192H96c0-75.1 26-136.3 62.4-175.7C78.5 42.7 9.2 99.5.1 175c-1.1 9.1 6.8 17 16 17h8.7l136.7 151.9c-.7 2.6-1.6 5.2-1.6 8.1v128c0 17.7 14.3 32 32 32h128c17.7 0 32-14.3 32-32V352c0-2.9-.9-5.4-1.6-8.1L487.1 192h8.7c9.3 0 17.2-7.8 16.1-17z"/></svg>]]
.pull-right-wide[### .white.bg-black[low employment turnover rates] <svg aria-hidden="true" role="img" viewBox="0 0 512 512" style="height:1em;width:1em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:blue;overflow:visible;position:relative;"><path d="M377.941 169.941V216H134.059v-46.059c0-21.382-25.851-32.09-40.971-16.971L7.029 239.029c-9.373 9.373-9.373 24.568 0 33.941l86.059 86.059c15.119 15.119 40.971 4.411 40.971-16.971V296h243.882v46.059c0 21.382 25.851 32.09 40.971 16.971l86.059-86.059c9.373-9.373 9.373-24.568 0-33.941l-86.059-86.059c-15.119-15.12-40.971-4.412-40.971 16.97z"/></svg> employees' loyalty]

--

.pull-left-narrow[
.center[### <svg aria-hidden="true" role="img" viewBox="0 0 448 512" style="height:1em;width:0.88em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:green;overflow:visible;position:relative;"><path d="M325.4 289.2L224 390.6 122.6 289.2C54 295.3 0 352.2 0 422.4V464c0 26.5 21.5 48 48 48h352c26.5 0 48-21.5 48-48v-41.6c0-70.2-54-127.1-122.6-133.2zM32 192c27.3 0 51.8-11.5 69.2-29.7 15.1 53.9 64 93.7 122.8 93.7 70.7 0 128-57.3 128-128S294.7 0 224 0c-50.4 0-93.6 29.4-114.5 71.8C92.1 47.8 64 32 32 32c0 33.4 17.1 62.8 43.1 80-26 17.2-43.1 46.6-43.1 80zm144-96h96c17.7 0 32 14.3 32 32H144c0-17.7 14.3-32 32-32z"/></svg>]]
.pull-right-wide[### accumulated .white.bg-black[firm-specific knowledge] <span>&lt;i class="fas  fa-wrench faa-wrench animated faa-slow " style=" color:blue;"&gt;&lt;/i&gt;</span>]

--

.pull-left-narrow[
.center[### <svg aria-hidden="true" role="img" viewBox="0 0 448 512" style="height:1em;width:0.88em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:green;overflow:visible;position:relative;"><path d="M64 224h13.5c24.7 56.5 80.9 96 146.5 96s121.8-39.5 146.5-96H384c8.8 0 16-7.2 16-16v-96c0-8.8-7.2-16-16-16h-13.5C345.8 39.5 289.6 0 224 0S102.2 39.5 77.5 96H64c-8.8 0-16 7.2-16 16v96c0 8.8 7.2 16 16 16zm40-88c0-22.1 21.5-40 48-40h144c26.5 0 48 17.9 48 40v24c0 53-43 96-96 96h-48c-53 0-96-43-96-96v-24zm72 72l12-36 36-12-36-12-12-36-12 36-36 12 36 12 12 36zm151.6 113.4C297.7 340.7 262.2 352 224 352s-73.7-11.3-103.6-30.6C52.9 328.5 0 385 0 454.4v9.6c0 26.5 21.5 48 48 48h80v-64c0-17.7 14.3-32 32-32h128c17.7 0 32 14.3 32 32v64h80c26.5 0 48-21.5 48-48v-9.6c0-69.4-52.9-125.9-120.4-133zM272 448c-8.8 0-16 7.2-16 16s7.2 16 16 16 16-7.2 16-16-7.2-16-16-16zm-96 0c-8.8 0-16 7.2-16 16v48h32v-48c0-8.8-7.2-16-16-16z"/></svg>]]
.pull-right-wide[### <span>&lt;i class="fas  fa-lightbulb faa-pulse animated faa-slow " style=" color:blue;"&gt;&lt;/i&gt;</span> .white.bg-black[routinized innovation model] <svg aria-hidden="true" role="img" viewBox="0 0 512 512" style="height:1em;width:1em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:blue;overflow:visible;position:relative;"><path d="M377.941 169.941V216H134.059v-46.059c0-21.382-25.851-32.09-40.971-16.971L7.029 239.029c-9.373 9.373-9.373 24.568 0 33.941l86.059 86.059c15.119 15.119 40.971 4.411 40.971-16.971V296h243.882v46.059c0 21.382 25.851 32.09 40.971 16.971l86.059-86.059c9.373-9.373 9.373-24.568 0-33.941l-86.059-86.059c-15.119-15.12-40.971-4.412-40.971 16.97z"/></svg> well-established R&amp;D departments]

---
class: highlight-last-item

# Why current research matters

- Japan has the .white.bg-black[3rd-largest] market capitalization for listed companies in the <svg aria-hidden="true" role="img" viewBox="0 0 496 512" style="height:1em;width:0.97em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:blue;overflow:visible;position:relative;"><path d="M248 8C111.03 8 0 119.03 0 256s111.03 248 248 248 248-111.03 248-248S384.97 8 248 8zm-11.34 240.23c-2.89 4.82-8.1 7.77-13.72 7.77h-.31c-4.24 0-8.31 1.69-11.31 4.69l-5.66 5.66c-3.12 3.12-3.12 8.19 0 11.31l5.66 5.66c3 3 4.69 7.07 4.69 11.31V304c0 8.84-7.16 16-16 16h-6.11c-6.06 0-11.6-3.42-14.31-8.85l-22.62-45.23c-2.44-4.88-8.95-5.94-12.81-2.08l-19.47 19.46c-3 3-7.07 4.69-11.31 4.69H50.81C49.12 277.55 48 266.92 48 256c0-110.28 89.72-200 200-200 21.51 0 42.2 3.51 61.63 9.82l-50.16 38.53c-5.11 3.41-4.63 11.06.86 13.81l10.83 5.41c5.42 2.71 8.84 8.25 8.84 14.31V216c0 4.42-3.58 8-8 8h-3.06c-3.03 0-5.8-1.71-7.15-4.42-1.56-3.12-5.96-3.29-7.76-.3l-17.37 28.95zM408 358.43c0 4.24-1.69 8.31-4.69 11.31l-9.57 9.57c-3 3-7.07 4.69-11.31 4.69h-15.16c-4.24 0-8.31-1.69-11.31-4.69l-13.01-13.01a26.767 26.767 0 0 0-25.42-7.04l-21.27 5.32c-1.27.32-2.57.48-3.88.48h-10.34c-4.24 0-8.31-1.69-11.31-4.69l-11.91-11.91a8.008 8.008 0 0 1-2.34-5.66v-10.2c0-3.27 1.99-6.21 5.03-7.43l39.34-15.74c1.98-.79 3.86-1.82 5.59-3.05l23.71-16.89a7.978 7.978 0 0 1 4.64-1.48h12.09c3.23 0 6.15 1.94 7.39 4.93l5.35 12.85a4 4 0 0 0 3.69 2.46h3.8c1.78 0 3.35-1.18 3.84-2.88l4.2-14.47c.5-1.71 2.06-2.88 3.84-2.88h6.06c2.21 0 4 1.79 4 4v12.93c0 2.12.84 4.16 2.34 5.66l11.91 11.91c3 3 4.69 7.07 4.69 11.31v24.6z"/></svg>

--

- both patenting quality and quantity are among the highest in the <svg aria-hidden="true" role="img" viewBox="0 0 496 512" style="height:1em;width:0.97em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:blue;overflow:visible;position:relative;"><path d="M248 8C111.03 8 0 119.03 0 256s111.03 248 248 248 248-111.03 248-248S384.97 8 248 8zm-11.34 240.23c-2.89 4.82-8.1 7.77-13.72 7.77h-.31c-4.24 0-8.31 1.69-11.31 4.69l-5.66 5.66c-3.12 3.12-3.12 8.19 0 11.31l5.66 5.66c3 3 4.69 7.07 4.69 11.31V304c0 8.84-7.16 16-16 16h-6.11c-6.06 0-11.6-3.42-14.31-8.85l-22.62-45.23c-2.44-4.88-8.95-5.94-12.81-2.08l-19.47 19.46c-3 3-7.07 4.69-11.31 4.69H50.81C49.12 277.55 48 266.92 48 256c0-110.28 89.72-200 200-200 21.51 0 42.2 3.51 61.63 9.82l-50.16 38.53c-5.11 3.41-4.63 11.06.86 13.81l10.83 5.41c5.42 2.71 8.84 8.25 8.84 14.31V216c0 4.42-3.58 8-8 8h-3.06c-3.03 0-5.8-1.71-7.15-4.42-1.56-3.12-5.96-3.29-7.76-.3l-17.37 28.95zM408 358.43c0 4.24-1.69 8.31-4.69 11.31l-9.57 9.57c-3 3-7.07 4.69-11.31 4.69h-15.16c-4.24 0-8.31-1.69-11.31-4.69l-13.01-13.01a26.767 26.767 0 0 0-25.42-7.04l-21.27 5.32c-1.27.32-2.57.48-3.88.48h-10.34c-4.24 0-8.31-1.69-11.31-4.69l-11.91-11.91a8.008 8.008 0 0 1-2.34-5.66v-10.2c0-3.27 1.99-6.21 5.03-7.43l39.34-15.74c1.98-.79 3.86-1.82 5.59-3.05l23.71-16.89a7.978 7.978 0 0 1 4.64-1.48h12.09c3.23 0 6.15 1.94 7.39 4.93l5.35 12.85a4 4 0 0 0 3.69 2.46h3.8c1.78 0 3.35-1.18 3.84-2.88l4.2-14.47c.5-1.71 2.06-2.88 3.84-2.88h6.06c2.21 0 4 1.79 4 4v12.93c0 2.12.84 4.16 2.34 5.66l11.91 11.91c3 3 4.69 7.07 4.69 11.31v24.6z"/></svg>

--

- distinct corporate institutional arrangements (.white.bg-black[relational finance] &amp; .white.bg-black[stakeholder governance]) <svg aria-hidden="true" role="img" viewBox="0 0 448 512" style="height:1em;width:0.88em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:blue;overflow:visible;position:relative;"><path d="M190.5 66.9l22.2-22.2c9.4-9.4 24.6-9.4 33.9 0L441 239c9.4 9.4 9.4 24.6 0 33.9L246.6 467.3c-9.4 9.4-24.6 9.4-33.9 0l-22.2-22.2c-9.5-9.5-9.3-25 .4-34.3L311.4 296H24c-13.3 0-24-10.7-24-24v-32c0-13.3 10.7-24 24-24h287.4L190.9 101.2c-9.8-9.3-10-24.8-.4-34.3z"/></svg>

--

- .white.bg-black[However], during the last 30 years, Japan has witnessed **institutional** <svg aria-hidden="true" role="img" viewBox="0 0 512 512" style="height:1em;width:1em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:blue;overflow:visible;position:relative;"><path d="M504.971 359.029c9.373 9.373 9.373 24.569 0 33.941l-80 79.984c-15.01 15.01-40.971 4.49-40.971-16.971V416h-58.785a12.004 12.004 0 0 1-8.773-3.812l-70.556-75.596 53.333-57.143L352 336h32v-39.981c0-21.438 25.943-31.998 40.971-16.971l80 79.981zM12 176h84l52.781 56.551 53.333-57.143-70.556-75.596A11.999 11.999 0 0 0 122.785 96H12c-6.627 0-12 5.373-12 12v56c0 6.627 5.373 12 12 12zm372 0v39.984c0 21.46 25.961 31.98 40.971 16.971l80-79.984c9.373-9.373 9.373-24.569 0-33.941l-80-79.981C409.943 24.021 384 34.582 384 56.019V96h-58.785a12.004 12.004 0 0 0-8.773 3.812L96 336H12c-6.627 0-12 5.373-12 12v56c0 6.627 5.373 12 12 12h110.785c3.326 0 6.503-1.381 8.773-3.812L352 176h32z"/></svg> , as **market influence** has <svg aria-hidden="true" role="img" viewBox="0 0 448 512" style="height:1em;width:0.88em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:blue;overflow:visible;position:relative;"><path d="M34.9 289.5l-22.2-22.2c-9.4-9.4-9.4-24.6 0-33.9L207 39c9.4-9.4 24.6-9.4 33.9 0l194.3 194.3c9.4 9.4 9.4 24.6 0 33.9L413 289.4c-9.5 9.5-25 9.3-34.3-.4L264 168.6V456c0 13.3-10.7 24-24 24h-32c-13.3 0-24-10.7-24-24V168.6L69.2 289.1c-9.3 9.8-24.8 10-34.3.4z"/></svg>

--

&lt;br&gt;

&lt;ru-blockquote&gt;Organizations are social communities in which individual and social expertise is transformed into economically useful products and services
.right[— &lt;cite&gt;Kogut and Zander (1992)&lt;/cite&gt;]&lt;/ru-blockquote&gt;

???

* legislation promoting market competition has been toughened -- 2005 amendment of Japan's Anti-Monopoly Act

* entry barriers lowered for pharmaceuticals during the late-1990s, which paved a path to a more intensive industrial competition

* similar processes have been observed in Japan's electric sector since mid-1990s, leading to a higher R&amp;D efficiency as well as more intensive patenting

* these developments invited further attention to changing market perceptions of corporate innovations amid the ongoing balance shift from the institutional towards a more market-based industrial model

---

# RQ &amp; Hypotheses

.black.bg-washed-green.b--dark-green.ba.bw2.br3.shadow-5.ph4.mt5[
How does Tokyo Stock Exchange (TSE) evaluate corporate innovations?]

--
&gt; **Hypothesis 1**
&gt;
TSE positively evaluates companies with higher R&amp;D expenditures.
This represents the .white.bg-black[institutional] aspect of corporate innovations.

--

&gt; **Hypothesis 2**
&gt;
TSE positively evaluates companies whose R&amp;D expenditures yield higher patent stocks.
This represents the .white.bg-black[quantitative-market] aspect of corporate innovative policies.

--

&gt; **Hypothesis 3**
&gt;
TSE positively evaluates influential patents judged by the number of citations accruing to them.
This represents the .white.bg-black[qualitative-market] aspect of innovative policies.

---

# Data

.panelset.sideways[
.panel[.panel-name[Size]

- 684 companies <svg aria-hidden="true" role="img" viewBox="0 0 352 512" style="height:1em;width:0.69em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:blue;overflow:visible;position:relative;"><path d="M242.72 256l100.07-100.07c12.28-12.28 12.28-32.19 0-44.48l-22.24-22.24c-12.28-12.28-32.19-12.28-44.48 0L176 189.28 75.93 89.21c-12.28-12.28-32.19-12.28-44.48 0L9.21 111.45c-12.28 12.28-12.28 32.19 0 44.48L109.28 256 9.21 356.07c-12.28 12.28-12.28 32.19 0 44.48l22.24 22.24c12.28 12.28 32.2 12.28 44.48 0L176 322.72l100.07 100.07c12.28 12.28 32.2 12.28 44.48 0l22.24-22.24c12.28-12.28 12.28-32.19 0-44.48L242.72 256z"/></svg> 19 years (1998 — 2016) <svg aria-hidden="true" role="img" viewBox="0 0 448 512" style="height:1em;width:0.88em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:blue;overflow:visible;position:relative;"><path d="M190.5 66.9l22.2-22.2c9.4-9.4 24.6-9.4 33.9 0L441 239c9.4 9.4 9.4 24.6 0 33.9L246.6 467.3c-9.4 9.4-24.6 9.4-33.9 0l-22.2-22.2c-9.5-9.5-9.3-25 .4-34.3L311.4 296H24c-13.3 0-24-10.7-24-24v-32c0-13.3 10.7-24 24-24h287.4L190.9 101.2c-9.8-9.3-10-24.8-.4-34.3z"/></svg>


- 12,996 observations <svg aria-hidden="true" role="img" viewBox="0 0 448 512" style="height:1em;width:0.88em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:blue;overflow:visible;position:relative;"><path d="M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z"/></svg> outliers <svg aria-hidden="true" role="img" viewBox="0 0 448 512" style="height:1em;width:0.88em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:blue;overflow:visible;position:relative;"><path d="M416 304H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32zm0-192H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z"/></svg> 8,038 observations. 
]


.panel[.panel-name[Sources]

- .white.bg-black[Nikkei NEEDS Financial Quest] 


- .white.bg-black[Institute of Intellectual Property Patent Database] (IIP-DB) (Goto and Motohashi, 2007)

]

.panel[.panel-name[Industries]


## <svg aria-hidden="true" role="img" viewBox="0 0 576 512" style="height:1em;width:1.12em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:green;overflow:visible;position:relative;"><path d="M555.3 300.1L424.2 112.8C401.9 81 366.4 64 330.4 64c-22.6 0-45.5 6.7-65.5 20.7-19.7 13.8-33.7 32.8-41.5 53.8C220.5 79.2 172 32 112 32 50.1 32 0 82.1 0 144v224c0 61.9 50.1 112 112 112s112-50.1 112-112V218.9c3.3 8.6 7.3 17.1 12.8 25L368 431.2c22.2 31.8 57.7 48.8 93.8 48.8 22.7 0 45.5-6.7 65.5-20.7 51.7-36.2 64.2-107.5 28-159.2zM160 256H64V144c0-26.5 21.5-48 48-48s48 21.5 48 48v112zm194.8 44.9l-65.6-93.7c-7.7-11-10.7-24.4-8.3-37.6 2.3-13.2 9.7-24.8 20.7-32.5 8.5-6 18.5-9.1 28.8-9.1 16.5 0 31.9 8 41.3 21.5l65.6 93.7-82.5 57.7z"/></svg> &amp;nbsp;&amp;nbsp;&amp;nbsp; Pharmaceutical


## <svg aria-hidden="true" role="img" viewBox="0 0 448 512" style="height:1em;width:0.88em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:green;overflow:visible;position:relative;"><path d="M302.5 512c23.18 0 44.43-12.58 56-32.66C374.69 451.26 384 418.75 384 384c0-36.12-10.08-69.81-27.44-98.62L400 241.94l9.38 9.38c6.25 6.25 16.38 6.25 22.63 0l11.3-11.32c6.25-6.25 6.25-16.38 0-22.63l-52.69-52.69c-6.25-6.25-16.38-6.25-22.63 0l-11.31 11.31c-6.25 6.25-6.25 16.38 0 22.63l9.38 9.38-39.41 39.41c-11.56-11.37-24.53-21.33-38.65-29.51V63.74l15.97-.02c8.82-.01 15.97-7.16 15.98-15.98l.04-31.72C320 7.17 312.82-.01 303.97 0L80.03.26c-8.82.01-15.97 7.16-15.98 15.98l-.04 31.73c-.01 8.85 7.17 16.02 16.02 16.01L96 63.96v153.93C38.67 251.1 0 312.97 0 384c0 34.75 9.31 67.27 25.5 95.34C37.08 499.42 58.33 512 81.5 512h221zM120.06 259.43L144 245.56V63.91l96-.11v181.76l23.94 13.87c24.81 14.37 44.12 35.73 56.56 60.57h-257c12.45-24.84 31.75-46.2 56.56-60.57z"/></svg> &amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Chemical


## <svg aria-hidden="true" role="img" viewBox="0 0 640 512" style="height:1em;width:1.25em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:green;overflow:visible;position:relative;"><path d="M544 224l-128-16-48-16h-24L227.158 44h39.509C278.333 44 288 41.375 288 38s-9.667-6-21.333-6H152v12h16v164h-48l-66.667-80H18.667L8 138.667V208h8v16h48v2.666l-64 8v42.667l64 8V288H16v16H8v69.333L18.667 384h34.667L120 304h48v164h-16v12h114.667c11.667 0 21.333-2.625 21.333-6s-9.667-6-21.333-6h-39.509L344 320h24l48-16 128-16c96-21.333 96-26.583 96-32 0-5.417 0-10.667-96-32z"/></svg> &amp;nbsp;&amp;nbsp; Machinery


## <svg aria-hidden="true" role="img" viewBox="0 0 576 512" style="height:1em;width:1.12em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:green;overflow:visible;position:relative;"><path d="M336 448H16c-8.84 0-16 7.16-16 16v32c0 8.84 7.16 16 16 16h320c8.84 0 16-7.16 16-16v-32c0-8.84-7.16-16-16-16zm208-320V80c0-8.84-7.16-16-16-16s-16 7.16-16 16v48h-32V80c0-8.84-7.16-16-16-16s-16 7.16-16 16v48h-16c-8.84 0-16 7.16-16 16v32c0 35.76 23.62 65.69 56 75.93v118.49c0 13.95-9.5 26.92-23.26 29.19C431.22 402.5 416 388.99 416 372v-28c0-48.6-39.4-88-88-88h-8V64c0-35.35-28.65-64-64-64H96C60.65 0 32 28.65 32 64v352h288V304h8c22.09 0 40 17.91 40 40v24.61c0 39.67 28.92 75.16 68.41 79.01C481.71 452.05 520 416.41 520 372V251.93c32.38-10.24 56-40.17 56-75.93v-32c0-8.84-7.16-16-16-16h-16zm-283.91 47.76l-93.7 139c-2.2 3.33-6.21 5.24-10.39 5.24-7.67 0-13.47-6.28-11.67-12.92L167.35 224H108c-7.25 0-12.85-5.59-11.89-11.89l16-107C112.9 99.9 117.98 96 124 96h68c7.88 0 13.62 6.54 11.6 13.21L192 160h57.7c9.24 0 15.01 8.78 10.39 15.76z"/></svg> &amp;nbsp;&amp;nbsp;&amp;nbsp; Electrical Equipment

]

]

---

# Timing of patent grants











.panelset[



.panel[.panel-name[Plot]

&lt;img src="AJBS-2021_files/figure-html/grant-timing-plot-1.png" width="864" style="display: block; margin: auto;" /&gt;

]

.panel[.panel-name[Table]

&lt;div align="center"&gt;

<div id="htmlwidget-9e515b3985327676cf0e" style="width:80%;height:auto;" class="datatables html-widget"></div>
<script type="application/json" data-for="htmlwidget-9e515b3985327676cf0e">{"x":{"filter":"none","fillContainer":false,"data":[["Chemical","Electronics","Machinery","Motor","Pharm","Precision","Cumulative"],[6.8678311138,7.2806806075,6.6383261542,6.5610150211,7.5873633189,7.6175217418,6.9049034312],[8.0895653498,8.6624237936,7.8321703889,8.2852152796,8.3353113833,8.9386238219,8.136566725],[7.6374046653,7.2942644412,6.727487592,7.165346061,8.2424995055,7.9291608331,6.9513845274],[4.80625630921429,4.37581515778571,4.5135435005,4.3744336665,5.041140204,4.65233222035714,4.55041489635714],[6.66444544586364,6.67352501436364,6.2538511445,6.39449624881818,7.09608420302273,7.04512988756818,6.44623534965909]],"container":"<table class=\"display\">\n  <thead>\n    <tr>\n      <th> <\/th>\n      <th>1971-1980<\/th>\n      <th>1981-1990<\/th>\n      <th>1991-2000<\/th>\n      <th>2001-2014<\/th>\n      <th>Combined<\/th>\n    <\/tr>\n  <\/thead>\n<\/table>","options":{"pageLength":9,"initComplete":"function(settings, json) {\n$(this.api().table().header()).css({'background-color': '#000', 'color': '#fff'});\n}","columnDefs":[{"targets":1,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatRound(data, 2, 3, \",\", \".\");\n  }"},{"targets":2,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatRound(data, 2, 3, \",\", \".\");\n  }"},{"targets":3,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatRound(data, 2, 3, \",\", \".\");\n  }"},{"targets":4,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatRound(data, 2, 3, \",\", \".\");\n  }"},{"targets":5,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatRound(data, 2, 3, \",\", \".\");\n  }"},{"className":"dt-right","targets":[1,2,3,4,5]},{"orderable":false,"targets":0}],"order":[],"autoWidth":false,"orderClasses":false,"lengthMenu":[9,10,25,50,100]}},"evals":["options.initComplete","options.columnDefs.0.render","options.columnDefs.1.render","options.columnDefs.2.render","options.columnDefs.3.render","options.columnDefs.4.render"],"jsHooks":[]}</script>
&lt;/div&gt;
]
]


???

# Plot

1. In 1994, the pre-grant opposition system was replaced for the post-grant one, thereby eliminating potential procedural delays.

2. In 1998, the punishments for the copy-rights infringements were severed.
Due to this, patentees had more solid reasons to seek for the legal protection of their inventions.

3. In 1999, the period for the compulsory request for patent examination was decreased from 7 to 3 years from the date of application.
Thereby, many applicants were prompted to speed up the registration of their inventions.


# Table

* Application-filing process is especially time-consuming for the **Pharmaceutical** industry, where the average period for granting a patent is 7.1 years -- well above the cumulative mean of 6.45 years.

* Although an average time for receiving a patent within the **Chemical** industry throughout 1971-2014 was roughly the same as within the Electronics, starting from 1990s Chemical-related applications have required more approval time than the Electric-related ones.

* Hence, especially for the period analyzed in this article, most challenging conditions for licensing appear to be in the **Chemical** and the related **Pharmaceutical** industries. 
This goes hand in hand with the importance of patenting activities for these sectors both in Japan and internationally.


---

# Patents-to-applications ratio
















.panelset[
.panel[.panel-name[Plot]

&lt;img src="AJBS-2021_files/figure-html/patrat-plot-1.png" width="864" style="display: block; margin: auto;" /&gt;

]

.panel[.panel-name[Table]

&lt;div align="center"&gt;

<div id="htmlwidget-08f667ce63d5d771cfa6" style="width:80%;height:auto;" class="datatables html-widget"></div>
<script type="application/json" data-for="htmlwidget-08f667ce63d5d771cfa6">{"x":{"filter":"none","fillContainer":false,"data":[["Chemical","Electronics","Machinery","Motor","Pharm","Precision","Cumulative"],[0.522728819,0.3123068955,0.4514961335,0.435988794,0.581978726,0.350781612,0.383791938],[0.4508416,0.240042963,0.3779378155,0.3795567845,0.5123684495,0.3785006805,0.331692055],[0.3419771845,0.281564448,0.380517602,0.425702542,0.358954486,0.2752460285,0.338913883],[0.549310446,0.456581515,0.515514157,0.501164316,0.503724032,0.4235396695,0.4896631685],[0.4840552475,0.3020817175,0.414529755,0.4362677675,0.503724032,0.3567717515,0.372653685]],"container":"<table class=\"display\">\n  <thead>\n    <tr>\n      <th> <\/th>\n      <th>1971-1980<\/th>\n      <th>1981-1990<\/th>\n      <th>1991-2000<\/th>\n      <th>2001-2014<\/th>\n      <th>Combined<\/th>\n    <\/tr>\n  <\/thead>\n<\/table>","options":{"pageLength":9,"initComplete":"function(settings, json) {\n$(this.api().table().header()).css({'background-color': '#000', 'color': '#fff'});\n}","columnDefs":[{"targets":1,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatRound(data, 2, 3, \",\", \".\");\n  }"},{"targets":2,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatRound(data, 2, 3, \",\", \".\");\n  }"},{"targets":3,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatRound(data, 2, 3, \",\", \".\");\n  }"},{"targets":4,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatRound(data, 2, 3, \",\", \".\");\n  }"},{"targets":5,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatRound(data, 2, 3, \",\", \".\");\n  }"},{"className":"dt-right","targets":[1,2,3,4,5]},{"orderable":false,"targets":0}],"order":[],"autoWidth":false,"orderClasses":false,"lengthMenu":[9,10,25,50,100]}},"evals":["options.initComplete","options.columnDefs.0.render","options.columnDefs.1.render","options.columnDefs.2.render","options.columnDefs.3.render","options.columnDefs.4.render"],"jsHooks":[]}</script>
&lt;/div&gt;
]
]


???

# Plot

* Median granting success rate of patents filed with the Japan Patent Office (JPO) from 1971 to 2014 was 37 percent. 
Very similar to the 35 percent in Germany and is considerably lower compared to countries such as France (90 percent) and the U.K. (80 percent) [griliches1998, p. 289]. 

* Although the granting rate has been on a sharp rise in Japan since early 2000s, it is still indicative of a stringent control mechanism that the local application process entails.


# Table

* comparatively high industrial success rates for **Pharmaceuticals** (50 percent) and **Chemicals** (48 percent) are a cause of patents being particularly important for realizing the gains from intangible assets.

* "In the **pharmaceutical** industry, patents are perceived as a relatively effective tool of appropriating rents from technological innovations as compared to other types of mechanism such as trade secret, increasing complexity of product design and faster market introduction" [Motohashi.2008, p. 1548].


---

#Methodology

--

- Market value of the firm, **V**, can be expressed as follows (Griliches, 1981):

`$$V_{it} = \alpha(A_{it} + \beta K_{it})$$`


&gt; where **A** — firm's tangible assets, **K** — knowledge stock, and `\(\alpha\)` — market valuation of the firm’s assets


--
&lt;br&gt;

- **Tobin's q** = .white.bg-black[market value] **V** / .white.bg-black[book value] **A** <svg aria-hidden="true" role="img" viewBox="0 0 448 512" style="height:1em;width:0.88em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:blue;overflow:visible;position:relative;"><path d="M190.5 66.9l22.2-22.2c9.4-9.4 24.6-9.4 33.9 0L441 239c9.4 9.4 9.4 24.6 0 33.9L246.6 467.3c-9.4 9.4-24.6 9.4-33.9 0l-22.2-22.2c-9.5-9.5-9.3-25 .4-34.3L311.4 296H24c-13.3 0-24-10.7-24-24v-32c0-13.3 10.7-24 24-24h287.4L190.9 101.2c-9.8-9.3-10-24.8-.4-34.3z"/></svg>

`$$q_t = \frac {V_{it}} {A_{it}} = \alpha \biggl(1 + \beta \frac {K_{it}} {A_{it}}\biggr) + \varepsilon_{it}$$`

--

- Knowledge stock **K**: .white.bg-black[R&amp;D / Tangible Assets], .white.bg-black[Patents per Japanese yen spent on R&amp;D], .white.bg-black[Citations per Patent] (Hall, Jaffe, and Trajtenberg, 2005) <svg aria-hidden="true" role="img" viewBox="0 0 448 512" style="height:1em;width:0.88em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:blue;overflow:visible;position:relative;"><path d="M190.5 66.9l22.2-22.2c9.4-9.4 24.6-9.4 33.9 0L441 239c9.4 9.4 9.4 24.6 0 33.9L246.6 467.3c-9.4 9.4-24.6 9.4-33.9 0l-22.2-22.2c-9.5-9.5-9.3-25 .4-34.3L311.4 296H24c-13.3 0-24-10.7-24-24v-32c0-13.3 10.7-24 24-24h287.4L190.9 101.2c-9.8-9.3-10-24.8-.4-34.3z"/></svg>

`$$\log q_{it} = \log \alpha_t + \log \biggl(1 + \beta_1 \frac {R\&amp;D_{it}} {A_{it}} + \beta_2 \frac {Pat_{it}} {R\&amp;D_{it}} + \beta_3 \frac {Cites_{it}} {Pat_{it}}\biggr) + \varepsilon_{it}$$`
???

To sum up, **Tobins's Q** can be expressed as the sum of knowledge stocks weighted by tangible assets.


---

# OLS regression


















&lt;table class="table table table-striped table-hover table-condensed" style="width: auto !important; margin-left: auto; margin-right: auto; font-size: 15px; margin-left: auto; margin-right: auto;"&gt;
 &lt;thead&gt;
  &lt;tr&gt;
   &lt;th style="text-align:left;color: white !important;background-color: black !important;"&gt;   &lt;/th&gt;
   &lt;th style="text-align:center;color: white !important;background-color: black !important;"&gt; OLS &lt;/th&gt;
   &lt;th style="text-align:center;color: white !important;background-color: black !important;"&gt; OLS (Industrial) &lt;/th&gt;
  &lt;/tr&gt;
 &lt;/thead&gt;
&lt;tbody&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; Constant &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -0.316 (0.055)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -0.407 (0.068)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; D (Electric) &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.069 (0.015)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.068 (0.076) &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; D (Machinery) &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.012 (0.029) &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.255 (0.069)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; D (Pharm) &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.356 (0.025)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.268 (0.132)* &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;color: white !important;background-color: grey !important;font-weight: bold;"&gt; R&amp;amp;D/Assets (x Chemical) &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: grey !important;"&gt; 0.019 (0.066) &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: grey !important;"&gt; 0.608 (0.096)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; R&amp;amp;D/Assets x Electric &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -0.288 (0.093)** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; R&amp;amp;D/Assets x Machinery &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.611 (0.178)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; R&amp;amp;D/Assets x Pharm &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.537 (0.204)** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;color: white !important;background-color: grey !important;font-weight: bold;"&gt; Patents/R&amp;amp;D (x Chemical) &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: grey !important;"&gt; 0.024 (0.081) &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: grey !important;"&gt; 1.018 (0.156)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; Patents/R&amp;amp;D x Electric &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -0.916 (0.207)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; Patents/R&amp;amp;D x Machinery &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -2.640 (0.251)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; Patents/R&amp;amp;D x Pharm &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -0.729 (0.520) &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;color: white !important;background-color: grey !important;font-weight: bold;"&gt; Citations/Patents (x Chemical) &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: grey !important;"&gt; 0.058 (0.013)*** &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: grey !important;"&gt; -0.014 (0.018) &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; Citations/Patents x Electric &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.187 (0.026)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; Citations/Patents x Machinery &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.103 (0.026)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; Citations/Patents x Pharm &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -0.033 (0.037) &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; R&amp;amp;D Intensity &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.738 (0.118)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.044 (0.130) &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; Process Innovation &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.033 (0.011)** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.032 (0.011)** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; Leverage &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 1.287 (0.038)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 1.086 (0.042)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; ROA &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 2.716 (0.106)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 2.656 (0.106)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; Capital Intensity &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.038 (0.005)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.045 (0.005)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;box-shadow: 0px 1pxfont-weight: bold;"&gt; Age &lt;/td&gt;
   &lt;td style="text-align:center;box-shadow: 0px 1px"&gt; -0.001 (0.000)*** &lt;/td&gt;
   &lt;td style="text-align:center;box-shadow: 0px 1px"&gt; -0.001 (0.000)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;color: white !important;background-color: blue !important;font-weight: bold;"&gt; Num.Obs. &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: blue !important;"&gt; 6903 &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: blue !important;"&gt; 6903 &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;color: white !important;background-color: blue !important;font-weight: bold;"&gt; R2 &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: blue !important;"&gt; 0.292 &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: blue !important;"&gt; 0.310 &lt;/td&gt;
  &lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;

---
count: false

# OLS regression

&lt;table class="table table table-striped table-hover table-condensed" style="width: auto !important; margin-left: auto; margin-right: auto; font-size: 15px; margin-left: auto; margin-right: auto;"&gt;
 &lt;thead&gt;
  &lt;tr&gt;
   &lt;th style="text-align:left;color: white !important;background-color: black !important;"&gt;   &lt;/th&gt;
   &lt;th style="text-align:center;color: white !important;background-color: black !important;"&gt; OLS &lt;/th&gt;
   &lt;th style="text-align:center;color: white !important;background-color: black !important;"&gt; OLS (Industrial) &lt;/th&gt;
  &lt;/tr&gt;
 &lt;/thead&gt;
&lt;tbody&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; Constant &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -0.316 (0.055)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -0.407 (0.068)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; D (Electric) &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.069 (0.015)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.068 (0.076) &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; D (Machinery) &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.012 (0.029) &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.255 (0.069)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;background-color: green !important;"&gt; D (Pharm) &lt;/td&gt;
   &lt;td style="text-align:center;background-color: green !important;"&gt; 0.356 (0.025)*** &lt;/td&gt;
   &lt;td style="text-align:center;background-color: green !important;"&gt; 0.268 (0.132)* &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;color: white !important;background-color: grey !important;font-weight: bold;"&gt; R&amp;amp;D/Assets (x Chemical) &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: grey !important;"&gt; 0.019 (0.066) &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: grey !important;"&gt; 0.608 (0.096)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; R&amp;amp;D/Assets x Electric &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -0.288 (0.093)** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; R&amp;amp;D/Assets x Machinery &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.611 (0.178)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; R&amp;amp;D/Assets x Pharm &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.537 (0.204)** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;color: white !important;background-color: grey !important;font-weight: bold;"&gt; Patents/R&amp;amp;D (x Chemical) &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: grey !important;"&gt; 0.024 (0.081) &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: grey !important;"&gt; 1.018 (0.156)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; Patents/R&amp;amp;D x Electric &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -0.916 (0.207)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; Patents/R&amp;amp;D x Machinery &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -2.640 (0.251)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; Patents/R&amp;amp;D x Pharm &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -0.729 (0.520) &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;color: white !important;background-color: grey !important;font-weight: bold;"&gt; Citations/Patents (x Chemical) &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: grey !important;"&gt; 0.058 (0.013)*** &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: grey !important;"&gt; -0.014 (0.018) &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; Citations/Patents x Electric &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.187 (0.026)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; Citations/Patents x Machinery &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.103 (0.026)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; Citations/Patents x Pharm &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -0.033 (0.037) &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; R&amp;amp;D Intensity &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.738 (0.118)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.044 (0.130) &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; Process Innovation &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.033 (0.011)** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.032 (0.011)** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; Leverage &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 1.287 (0.038)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 1.086 (0.042)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; ROA &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 2.716 (0.106)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 2.656 (0.106)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; Capital Intensity &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.038 (0.005)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.045 (0.005)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;box-shadow: 0px 1pxfont-weight: bold;"&gt; Age &lt;/td&gt;
   &lt;td style="text-align:center;box-shadow: 0px 1px"&gt; -0.001 (0.000)*** &lt;/td&gt;
   &lt;td style="text-align:center;box-shadow: 0px 1px"&gt; -0.001 (0.000)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;color: white !important;background-color: blue !important;font-weight: bold;"&gt; Num.Obs. &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: blue !important;"&gt; 6903 &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: blue !important;"&gt; 6903 &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;color: white !important;background-color: blue !important;font-weight: bold;"&gt; R2 &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: blue !important;"&gt; 0.292 &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: blue !important;"&gt; 0.310 &lt;/td&gt;
  &lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;

???

# Industrial premium

* Belonging to **Pharmaceuticals** per se implies a premium in terms of market valuation of corporate knowledge assets. 


---
count: false

# OLS regression

&lt;table class="table table table-striped table-hover table-condensed" style="width: auto !important; margin-left: auto; margin-right: auto; font-size: 15px; margin-left: auto; margin-right: auto;"&gt;
 &lt;thead&gt;
  &lt;tr&gt;
   &lt;th style="text-align:left;color: white !important;background-color: black !important;"&gt;   &lt;/th&gt;
   &lt;th style="text-align:center;color: white !important;background-color: black !important;"&gt; OLS &lt;/th&gt;
   &lt;th style="text-align:center;color: white !important;background-color: black !important;"&gt; OLS (Industrial) &lt;/th&gt;
  &lt;/tr&gt;
 &lt;/thead&gt;
&lt;tbody&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; Constant &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -0.316 (0.055)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -0.407 (0.068)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; D (Electric) &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.069 (0.015)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.068 (0.076) &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; D (Machinery) &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.012 (0.029) &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.255 (0.069)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; D (Pharm) &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.356 (0.025)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.268 (0.132)* &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;color: white !important;background-color: grey !important;font-weight: bold;background-color: green !important;"&gt; R&amp;amp;D/Assets (x Chemical) &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: grey !important;background-color: green !important;"&gt; 0.019 (0.066) &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: grey !important;background-color: green !important;"&gt; 0.608 (0.096)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; R&amp;amp;D/Assets x Electric &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -0.288 (0.093)** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;background-color: green !important;" indentlevel="1"&gt; R&amp;amp;D/Assets x Machinery &lt;/td&gt;
   &lt;td style="text-align:center;background-color: green !important;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;background-color: green !important;"&gt; 0.611 (0.178)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;background-color: green !important;" indentlevel="1"&gt; R&amp;amp;D/Assets x Pharm &lt;/td&gt;
   &lt;td style="text-align:center;background-color: green !important;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;background-color: green !important;"&gt; 0.537 (0.204)** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;color: white !important;background-color: grey !important;font-weight: bold;"&gt; Patents/R&amp;amp;D (x Chemical) &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: grey !important;"&gt; 0.024 (0.081) &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: grey !important;"&gt; 1.018 (0.156)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; Patents/R&amp;amp;D x Electric &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -0.916 (0.207)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; Patents/R&amp;amp;D x Machinery &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -2.640 (0.251)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; Patents/R&amp;amp;D x Pharm &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -0.729 (0.520) &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;color: white !important;background-color: grey !important;font-weight: bold;"&gt; Citations/Patents (x Chemical) &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: grey !important;"&gt; 0.058 (0.013)*** &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: grey !important;"&gt; -0.014 (0.018) &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; Citations/Patents x Electric &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.187 (0.026)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; Citations/Patents x Machinery &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.103 (0.026)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; Citations/Patents x Pharm &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -0.033 (0.037) &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; R&amp;amp;D Intensity &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.738 (0.118)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.044 (0.130) &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; Process Innovation &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.033 (0.011)** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.032 (0.011)** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; Leverage &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 1.287 (0.038)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 1.086 (0.042)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; ROA &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 2.716 (0.106)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 2.656 (0.106)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; Capital Intensity &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.038 (0.005)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.045 (0.005)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;box-shadow: 0px 1pxfont-weight: bold;"&gt; Age &lt;/td&gt;
   &lt;td style="text-align:center;box-shadow: 0px 1px"&gt; -0.001 (0.000)*** &lt;/td&gt;
   &lt;td style="text-align:center;box-shadow: 0px 1px"&gt; -0.001 (0.000)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;color: white !important;background-color: blue !important;font-weight: bold;"&gt; Num.Obs. &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: blue !important;"&gt; 6903 &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: blue !important;"&gt; 6903 &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;color: white !important;background-color: blue !important;font-weight: bold;"&gt; R2 &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: blue !important;"&gt; 0.292 &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: blue !important;"&gt; 0.310 &lt;/td&gt;
  &lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;

???

# R&amp;D stock

* **Drugs** are notable for the marketability of their R&amp;D expenditures (R&amp;D stock weighted by Assets).

* The same holds true about the positive assessment of R&amp;D stocks for **Chemicals** and **Machinery**.


---
count: false

# OLS regression

&lt;table class="table table table-striped table-hover table-condensed" style="width: auto !important; margin-left: auto; margin-right: auto; font-size: 15px; margin-left: auto; margin-right: auto;"&gt;
 &lt;thead&gt;
  &lt;tr&gt;
   &lt;th style="text-align:left;color: white !important;background-color: black !important;"&gt;   &lt;/th&gt;
   &lt;th style="text-align:center;color: white !important;background-color: black !important;"&gt; OLS &lt;/th&gt;
   &lt;th style="text-align:center;color: white !important;background-color: black !important;"&gt; OLS (Industrial) &lt;/th&gt;
  &lt;/tr&gt;
 &lt;/thead&gt;
&lt;tbody&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; Constant &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -0.316 (0.055)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -0.407 (0.068)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; D (Electric) &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.069 (0.015)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.068 (0.076) &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; D (Machinery) &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.012 (0.029) &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.255 (0.069)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; D (Pharm) &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.356 (0.025)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.268 (0.132)* &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;color: white !important;background-color: grey !important;font-weight: bold;"&gt; R&amp;amp;D/Assets (x Chemical) &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: grey !important;"&gt; 0.019 (0.066) &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: grey !important;"&gt; 0.608 (0.096)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; R&amp;amp;D/Assets x Electric &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -0.288 (0.093)** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; R&amp;amp;D/Assets x Machinery &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.611 (0.178)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; R&amp;amp;D/Assets x Pharm &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.537 (0.204)** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;color: white !important;background-color: grey !important;font-weight: bold;background-color: green !important;"&gt; Patents/R&amp;amp;D (x Chemical) &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: grey !important;background-color: green !important;"&gt; 0.024 (0.081) &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: grey !important;background-color: green !important;"&gt; 1.018 (0.156)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; Patents/R&amp;amp;D x Electric &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -0.916 (0.207)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; Patents/R&amp;amp;D x Machinery &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -2.640 (0.251)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; Patents/R&amp;amp;D x Pharm &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -0.729 (0.520) &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;color: white !important;background-color: grey !important;font-weight: bold;"&gt; Citations/Patents (x Chemical) &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: grey !important;"&gt; 0.058 (0.013)*** &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: grey !important;"&gt; -0.014 (0.018) &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; Citations/Patents x Electric &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.187 (0.026)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; Citations/Patents x Machinery &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.103 (0.026)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; Citations/Patents x Pharm &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -0.033 (0.037) &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; R&amp;amp;D Intensity &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.738 (0.118)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.044 (0.130) &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; Process Innovation &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.033 (0.011)** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.032 (0.011)** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; Leverage &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 1.287 (0.038)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 1.086 (0.042)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; ROA &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 2.716 (0.106)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 2.656 (0.106)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; Capital Intensity &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.038 (0.005)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.045 (0.005)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;box-shadow: 0px 1pxfont-weight: bold;"&gt; Age &lt;/td&gt;
   &lt;td style="text-align:center;box-shadow: 0px 1px"&gt; -0.001 (0.000)*** &lt;/td&gt;
   &lt;td style="text-align:center;box-shadow: 0px 1px"&gt; -0.001 (0.000)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;color: white !important;background-color: blue !important;font-weight: bold;"&gt; Num.Obs. &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: blue !important;"&gt; 6903 &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: blue !important;"&gt; 6903 &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;color: white !important;background-color: blue !important;font-weight: bold;"&gt; R2 &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: blue !important;"&gt; 0.292 &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: blue !important;"&gt; 0.310 &lt;/td&gt;
  &lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;


???

# Patents per Japanese Yes spent on R&amp;D

* Only **Chemicals** stand out for their R&amp;D spending that translates into more inventions valued by market. 


---
count: false

# OLS regression

&lt;table class="table table table-striped table-hover table-condensed" style="width: auto !important; margin-left: auto; margin-right: auto; font-size: 15px; margin-left: auto; margin-right: auto;"&gt;
 &lt;thead&gt;
  &lt;tr&gt;
   &lt;th style="text-align:left;color: white !important;background-color: black !important;"&gt;   &lt;/th&gt;
   &lt;th style="text-align:center;color: white !important;background-color: black !important;"&gt; OLS &lt;/th&gt;
   &lt;th style="text-align:center;color: white !important;background-color: black !important;"&gt; OLS (Industrial) &lt;/th&gt;
  &lt;/tr&gt;
 &lt;/thead&gt;
&lt;tbody&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; Constant &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -0.316 (0.055)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -0.407 (0.068)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; D (Electric) &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.069 (0.015)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.068 (0.076) &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; D (Machinery) &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.012 (0.029) &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.255 (0.069)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; D (Pharm) &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.356 (0.025)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.268 (0.132)* &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;color: white !important;background-color: grey !important;font-weight: bold;"&gt; R&amp;amp;D/Assets (x Chemical) &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: grey !important;"&gt; 0.019 (0.066) &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: grey !important;"&gt; 0.608 (0.096)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; R&amp;amp;D/Assets x Electric &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -0.288 (0.093)** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; R&amp;amp;D/Assets x Machinery &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.611 (0.178)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; R&amp;amp;D/Assets x Pharm &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.537 (0.204)** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;color: white !important;background-color: grey !important;font-weight: bold;"&gt; Patents/R&amp;amp;D (x Chemical) &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: grey !important;"&gt; 0.024 (0.081) &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: grey !important;"&gt; 1.018 (0.156)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; Patents/R&amp;amp;D x Electric &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -0.916 (0.207)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; Patents/R&amp;amp;D x Machinery &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -2.640 (0.251)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; Patents/R&amp;amp;D x Pharm &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -0.729 (0.520) &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;color: white !important;background-color: grey !important;font-weight: bold;"&gt; Citations/Patents (x Chemical) &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: grey !important;"&gt; 0.058 (0.013)*** &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: grey !important;"&gt; -0.014 (0.018) &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;background-color: green !important;" indentlevel="1"&gt; Citations/Patents x Electric &lt;/td&gt;
   &lt;td style="text-align:center;background-color: green !important;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;background-color: green !important;"&gt; 0.187 (0.026)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;background-color: green !important;" indentlevel="1"&gt; Citations/Patents x Machinery &lt;/td&gt;
   &lt;td style="text-align:center;background-color: green !important;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;background-color: green !important;"&gt; 0.103 (0.026)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;padding-left: 6em;font-weight: bold;" indentlevel="1"&gt; Citations/Patents x Pharm &lt;/td&gt;
   &lt;td style="text-align:center;"&gt;  &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; -0.033 (0.037) &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; R&amp;amp;D Intensity &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.738 (0.118)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.044 (0.130) &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; Process Innovation &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.033 (0.011)** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.032 (0.011)** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; Leverage &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 1.287 (0.038)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 1.086 (0.042)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; ROA &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 2.716 (0.106)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 2.656 (0.106)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;font-weight: bold;"&gt; Capital Intensity &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.038 (0.005)*** &lt;/td&gt;
   &lt;td style="text-align:center;"&gt; 0.045 (0.005)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;box-shadow: 0px 1pxfont-weight: bold;"&gt; Age &lt;/td&gt;
   &lt;td style="text-align:center;box-shadow: 0px 1px"&gt; -0.001 (0.000)*** &lt;/td&gt;
   &lt;td style="text-align:center;box-shadow: 0px 1px"&gt; -0.001 (0.000)*** &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;color: white !important;background-color: blue !important;font-weight: bold;"&gt; Num.Obs. &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: blue !important;"&gt; 6903 &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: blue !important;"&gt; 6903 &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;color: white !important;background-color: blue !important;font-weight: bold;"&gt; R2 &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: blue !important;"&gt; 0.292 &lt;/td&gt;
   &lt;td style="text-align:center;color: white !important;background-color: blue !important;"&gt; 0.310 &lt;/td&gt;
  &lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;


???

# Citations per Patent

* **Electrical Equipment** and **Machinery**: peculiar for receiving market premium for more influential patents.


---
# Generalized Additive Models (GAMs)






.panelset[
.panel[.panel-name[R&amp;D]

&lt;img src="AJBS-2021_files/figure-html/gamrd-1.png" width="648" style="display: block; margin: auto;" /&gt;

]

.panel[.panel-name[Patent per R&amp;D yen]

&lt;img src="AJBS-2021_files/figure-html/gampatrd-1.png" width="648" style="display: block; margin: auto;" /&gt;

]

.panel[.panel-name[Citations per Patent]

&lt;img src="AJBS-2021_files/figure-html/gamcitpat-1.png" width="648" style="display: block; margin: auto;" /&gt;

]

.panel[.panel-name[R&amp;D Intensity]

&lt;img src="AJBS-2021_files/figure-html/gamrdint-1.png" width="648" style="display: block; margin: auto;" /&gt;

]

.panel[.panel-name[Process Innovation]

&lt;img src="AJBS-2021_files/figure-html/gamproc-1.png" width="648" style="display: block; margin: auto;" /&gt;

]










.panel[.panel-name[Age]

&lt;img src="AJBS-2021_files/figure-html/gamage-1.png" width="648" style="display: block; margin: auto;" /&gt;

]

]


???

* With the medium age of the companies analyzed being 59 years, it can be concluded from the Figure that TSE expects companies with the age below this median value to be *less* innovative as they get older.

* The opposite also holds true: firms that passed the median-age threshold are seen to be more likely to generate knowledge as their age increases.

* In other words, new market entrants as well as the undoubtedly experienced players tend to be more attractive to investors.


---

# Conclusions

--

&gt; 
**1.** Institutional features associated with .white.bg-black[R&amp;D spending] provide valuable signals for investors across multiple industries.
&gt;

&lt;br&gt;

--

&gt; 
**2.** Quality of a patented output .white.bg-black[(Citations per Patent)] mostly matters for the manufacturing sector.
&gt;

&lt;br&gt;

--

&gt; 
**3.** Pronounced nonlinear trend in the market perception of .white.bg-black[corporate age]: only the more experienced companies receive market premium as they get older.
&gt;


---

# References

Goto, A. and K. Motohashi (2007). "Construction of a Japanese Patent
Database and a First Look at Japanese Patenting Activities". En. In:
_Research Policy_ 36.9, pp. 1431-1442. ISSN: 00487333. DOI:
[10.1016/j.respol.2007.06.005](https://doi.org/10.1016%2Fj.respol.2007.06.005).

Griliches, Z. (1981). "Market Value, R&amp;D, and Patents". En. In:
_Economics Letters_ 7.2, pp. 183-187. ISSN: 0165-1765. DOI:
[10.1016/0165-1765(87)90114-5](https://doi.org/10.1016%2F0165-1765%2887%2990114-5).

Hall, B. H., A. Jaffe, and M. Trajtenberg (2005). "Market Value and
Patent Citations". In: _RAND Journal of economics_, pp. 16-38. ISSN:
0741-6261.

Kogut, B. and U. Zander (1992). "Knowledge of the Firm, Combinative
Capabilities, and the Replication of Technology". In: _Organization
Science_ 3.3, pp. 383-397. ISSN: 1047-7039. DOI:
[10.1287/orsc.3.3.383](https://doi.org/10.1287%2Forsc.3.3.383).

---

class: title-slide-final, middle
background-image: url(assets/img/AJBS.png)
background-size: 200px
background-position: 5% 5%

# Thank You for Your attention!

## Questions / Suggestions?

### You can access the presentation &amp; contact me <svg aria-hidden="true" role="img" viewBox="0 0 512 512" style="height:1em;width:1em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:#cc0033;overflow:visible;position:relative;"><path d="M504 256c0 137-111 248-248 248S8 393 8 256 119 8 256 8s248 111 248 248zM212 140v116h-70.9c-10.7 0-16.1 13-8.5 20.5l114.9 114.3c4.7 4.7 12.2 4.7 16.9 0l114.9-114.3c7.6-7.6 2.2-20.5-8.5-20.5H300V140c0-6.6-5.4-12-12-12h-64c-6.6 0-12 5.4-12 12z"/></svg>

|                                                                                                            |                                   |
| :--------------------------------------------------------------------------------------------------------- | :-------------------------------- |
| &lt;a href="mailto:ovsiannikov@kochi-tech.ac.jp"&gt;<svg aria-hidden="true" role="img" viewBox="0 0 512 512" style="height:1em;width:1em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:#cc0033;overflow:visible;position:relative;"><path d="M476 3.2L12.5 270.6c-18.1 10.4-15.8 35.6 2.2 43.2L121 358.4l287.3-253.2c5.5-4.9 13.3 2.6 8.6 8.3L176 407v80.5c0 23.6 28.5 32.9 42.5 15.8L282 426l124.6 52.2c14.2 6 30.4-2.9 33-18.2l72-432C515 7.8 493.3-6.8 476 3.2z"/></svg>          | ovsiannikov@kochi-tech.ac.jp |
|                                                                                                |                              |
| &lt;a href="https://kovsiannikov.com/slides/ajbs-2021/ajbs-2021"&gt;<svg aria-hidden="true" role="img" viewBox="0 0 512 512" style="height:1em;width:1em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:#cc0033;overflow:visible;position:relative;"><path d="M326.612 185.391c59.747 59.809 58.927 155.698.36 214.59-.11.12-.24.25-.36.37l-67.2 67.2c-59.27 59.27-155.699 59.262-214.96 0-59.27-59.26-59.27-155.7 0-214.96l37.106-37.106c9.84-9.84 26.786-3.3 27.294 10.606.648 17.722 3.826 35.527 9.69 52.721 1.986 5.822.567 12.262-3.783 16.612l-13.087 13.087c-28.026 28.026-28.905 73.66-1.155 101.96 28.024 28.579 74.086 28.749 102.325.51l67.2-67.19c28.191-28.191 28.073-73.757 0-101.83-3.701-3.694-7.429-6.564-10.341-8.569a16.037 16.037 0 0 1-6.947-12.606c-.396-10.567 3.348-21.456 11.698-29.806l21.054-21.055c5.521-5.521 14.182-6.199 20.584-1.731a152.482 152.482 0 0 1 20.522 17.197zM467.547 44.449c-59.261-59.262-155.69-59.27-214.96 0l-67.2 67.2c-.12.12-.25.25-.36.37-58.566 58.892-59.387 154.781.36 214.59a152.454 152.454 0 0 0 20.521 17.196c6.402 4.468 15.064 3.789 20.584-1.731l21.054-21.055c8.35-8.35 12.094-19.239 11.698-29.806a16.037 16.037 0 0 0-6.947-12.606c-2.912-2.005-6.64-4.875-10.341-8.569-28.073-28.073-28.191-73.639 0-101.83l67.2-67.19c28.239-28.239 74.3-28.069 102.325.51 27.75 28.3 26.872 73.934-1.155 101.96l-13.087 13.087c-4.35 4.35-5.769 10.79-3.783 16.612 5.864 17.194 9.042 34.999 9.69 52.721.509 13.906 17.454 20.446 27.294 10.606l37.106-37.106c59.271-59.259 59.271-155.699.001-214.959z"/></svg> | kovsiannikov.com             |
    </textarea>
<style data-target="print-only">@media screen {.remark-slide-container{display:block;}.remark-slide-scaler{box-shadow:none;}}</style>
<script src="https://remarkjs.com/downloads/remark-latest.min.js"></script>
<script src="macros.js"></script>
<script>var slideshow = remark.create({
"highlightStyle": "github",
"highlightLines": true,
"countIncrementalSlides": false,
"ratio": "16:9"
});
if (window.HTMLWidgets) slideshow.on('afterShowSlide', function (slide) {
  window.dispatchEvent(new Event('resize'));
});
(function(d) {
  var s = d.createElement("style"), r = d.querySelector(".remark-slide-scaler");
  if (!r) return;
  s.type = "text/css"; s.innerHTML = "@page {size: " + r.style.width + " " + r.style.height +"; }";
  d.head.appendChild(s);
})(document);

(function(d) {
  var el = d.getElementsByClassName("remark-slides-area");
  if (!el) return;
  var slide, slides = slideshow.getSlides(), els = el[0].children;
  for (var i = 1; i < slides.length; i++) {
    slide = slides[i];
    if (slide.properties.continued === "true" || slide.properties.count === "false") {
      els[i - 1].className += ' has-continuation';
    }
  }
  var s = d.createElement("style");
  s.type = "text/css"; s.innerHTML = "@media print { .has-continuation { display: none; } }";
  d.head.appendChild(s);
})(document);
// delete the temporary CSS (for displaying all slides initially) when the user
// starts to view slides
(function() {
  var deleted = false;
  slideshow.on('beforeShowSlide', function(slide) {
    if (deleted) return;
    var sheets = document.styleSheets, node;
    for (var i = 0; i < sheets.length; i++) {
      node = sheets[i].ownerNode;
      if (node.dataset["target"] !== "print-only") continue;
      node.parentNode.removeChild(node);
    }
    deleted = true;
  });
})();
(function() {
  "use strict"
  // Replace <script> tags in slides area to make them executable
  var scripts = document.querySelectorAll(
    '.remark-slides-area .remark-slide-container script'
  );
  if (!scripts.length) return;
  for (var i = 0; i < scripts.length; i++) {
    var s = document.createElement('script');
    var code = document.createTextNode(scripts[i].textContent);
    s.appendChild(code);
    var scriptAttrs = scripts[i].attributes;
    for (var j = 0; j < scriptAttrs.length; j++) {
      s.setAttribute(scriptAttrs[j].name, scriptAttrs[j].value);
    }
    scripts[i].parentElement.replaceChild(s, scripts[i]);
  }
})();
(function() {
  var links = document.getElementsByTagName('a');
  for (var i = 0; i < links.length; i++) {
    if (/^(https?:)?\/\//.test(links[i].getAttribute('href'))) {
      links[i].target = '_blank';
    }
  }
})();
// adds .remark-code-has-line-highlighted class to <pre> parent elements
// of code chunks containing highlighted lines with class .remark-code-line-highlighted
(function(d) {
  const hlines = d.querySelectorAll('.remark-code-line-highlighted');
  const preParents = [];
  const findPreParent = function(line, p = 0) {
    if (p > 1) return null; // traverse up no further than grandparent
    const el = line.parentElement;
    return el.tagName === "PRE" ? el : findPreParent(el, ++p);
  };

  for (let line of hlines) {
    let pre = findPreParent(line);
    if (pre && !preParents.includes(pre)) preParents.push(pre);
  }
  preParents.forEach(p => p.classList.add("remark-code-has-line-highlighted"));
})(document);</script>

<script>
slideshow._releaseMath = function(el) {
  var i, text, code, codes = el.getElementsByTagName('code');
  for (i = 0; i < codes.length;) {
    code = codes[i];
    if (code.parentNode.tagName !== 'PRE' && code.childElementCount === 0) {
      text = code.textContent;
      if (/^\\\((.|\s)+\\\)$/.test(text) || /^\\\[(.|\s)+\\\]$/.test(text) ||
          /^\$\$(.|\s)+\$\$$/.test(text) ||
          /^\\begin\{([^}]+)\}(.|\s)+\\end\{[^}]+\}$/.test(text)) {
        code.outerHTML = code.innerHTML;  // remove <code></code>
        continue;
      }
    }
    i++;
  }
};
slideshow._releaseMath(document);
</script>
<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
(function () {
  var script = document.createElement('script');
  script.type = 'text/javascript';
  script.src  = 'https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-MML-AM_CHTML';
  if (location.protocol !== 'file:' && /^https?:/.test(script.src))
    script.src  = script.src.replace(/^https?:/, '');
  document.getElementsByTagName('head')[0].appendChild(script);
})();
</script>
  </body>
</html>
